Log in to save to my catalogue

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cel...

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b4e23a2ec6b43d29b08dcb92f281971

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Autologous anti-CD19 chimeric antigen receptor (CAR) T cells are now used in routine practice for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Severe (grade ≥ 3) cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS) are still the most concerning acute toxicities leading to frequent intensive care unit...

Alternative Titles

Full title

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8b4e23a2ec6b43d29b08dcb92f281971

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b4e23a2ec6b43d29b08dcb92f281971

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-024-01579-w

How to access this item